Compass Therapeutics Inc (CMPX)
1.40
+0.04
(+2.94%)
USD |
NASDAQ |
May 31, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Total Liabilities (Quarterly): 4.082M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.082M |
| December 31, 2023 | 8.337M |
| September 30, 2023 | 9.993M |
| June 30, 2023 | 10.90M |
| March 31, 2023 | 12.71M |
| December 31, 2022 | 18.01M |
| September 30, 2022 | 11.72M |
| June 30, 2022 | 13.33M |
| March 31, 2022 | 12.07M |
| Date | Value |
|---|---|
| December 31, 2021 | 13.68M |
| September 30, 2021 | 11.01M |
| June 30, 2021 | 12.00M |
| March 31, 2021 | 14.73M |
| December 31, 2020 | 11.97M |
| September 30, 2020 | 13.40M |
| June 30, 2020 | 17.20M |
| December 31, 2019 | 148.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.082M
Minimum
Mar 2024
148.98M
Maximum
Dec 2019
20.24M
Average
12.07M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 161.14M |
| Shareholders Equity (Quarterly) | 157.06M |